Home Boronic Acids 1401222-64-7
1401222-64-7,MFCD14702534
Catalog No.:AA009DBY

1401222-64-7 | 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenylsulfonyl)morpholine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$17.00   $12.00
- +
1g
98%
in stock  
$44.00   $31.00
- +
5g
98%
in stock  
$164.00   $115.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA009DBY
Chemical Name:
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenylsulfonyl)morpholine
CAS Number:
1401222-64-7
Molecular Formula:
C16H24BNO5S
Molecular Weight:
353.2415
MDL Number:
MFCD14702534
SMILES:
CC1(C)OB(OC1(C)C)c1ccc(cc1)S(=O)(=O)N1CCOCC1
Properties
Computed Properties
 
Complexity:
529  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
6  
Rotatable Bond Count:
3  

Downstream Synthesis Route
834-67-3    73183-34-3   
4-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine 

[1]Devine,William;Woodring,JenniferL.;Swaminathan,Uma;Amata,Emanuele;Patel,Gautam;Erath,Jessey;Roncal,NormaE.;Lee,PatriciaJ.;Leed,SusanE.;Rodriguez,Ana;Mensa-Wilmot,Kojo;Sciotti,RichardJ.;Pollastri,MichaelP.[JournalofMedicinalChemistry,2015,vol.58,#14,p.5522-5537]

[2]CurrentPatentAssignee:KARYOPHARMTHERAPEUTICSINC-WO2015/3166,2015,A1Locationinpatent:Paragraph00451

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2005/30770,2005,A1Locationinpatent:Page/Pagecolumn25

[4]CurrentPatentAssignee:HUTCHISONCHINAMEDITECHLTD.-US2014/121200,2014,A1Locationinpatent:Paragraph0274;0276

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2005/30770,2005,A1Locationinpatent:Page/Pagecolumn25

[1]Liu,Jing;Zhang,Weihe;Stashko,MichaelA.;DeRyckere,Deborah;Cummings,ChristopherT.;Hunter,Debra;Yang,Chao;Jayakody,ChaturaN.;Cheng,Nancy;Simpson,Catherine;Norris-Drouin,Jacqueline;Sather,Susan;Kireev,Dmitri;Janzen,WilliamP.;Earp,H.Shelton;Graham,DouglasK.;Frye,StephenV.;Wang,Xiaodong[EuropeanJournalofMedicinalChemistry,2013,vol.65,p.83-93]

[1]CurrentPatentAssignee:HUTCHISONCHINAMEDITECHLTD.-US2014/121200,2014,A1

[2]Devine,William;Woodring,JenniferL.;Swaminathan,Uma;Amata,Emanuele;Patel,Gautam;Erath,Jessey;Roncal,NormaE.;Lee,PatriciaJ.;Leed,SusanE.;Rodriguez,Ana;Mensa-Wilmot,Kojo;Sciotti,RichardJ.;Pollastri,MichaelP.[JournalofMedicinalChemistry,2015,vol.58,#14,p.5522-5537]

[1]Devine,William;Woodring,JenniferL.;Swaminathan,Uma;Amata,Emanuele;Patel,Gautam;Erath,Jessey;Roncal,NormaE.;Lee,PatriciaJ.;Leed,SusanE.;Rodriguez,Ana;Mensa-Wilmot,Kojo;Sciotti,RichardJ.;Pollastri,MichaelP.[JournalofMedicinalChemistry,2015,vol.58,#14,p.5522-5537]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1401222-64-7 Molecular Formula|1401222-64-7 MDL|1401222-64-7 SMILES|1401222-64-7 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenylsulfonyl)morpholine